GGrantIndex
← Leaderboards

Robert R. Edelman

Beth Israel Deaconess Medical Center

$10,829,918
Attributed
$10,829,918
Total exposure
16
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,829,918 · 16

By mechanism

R01$8,986,605 · 7
R21$1,271,841 · 3
M01$571,472 · 6

Top collaborators

No co-investigators on record.

Most similar at Beth Israel Deaconess Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Contrast Media

Research focus

Contrast MediaMagnetic Resonance ImagingAngiographyImageCostMorphologic ArtifactsBlood VesselsSignal TransductionBasePhysiologic PulseScanningTissuesResolutionDiagnostic AccuracyHuman SubjectClinical ResearchContrast EnhancedBloodKidneyGadoliniumFrequenciesCardiovascular SystemImpaired Renal FunctionNoise

Grant awards (41)

Improved Detection of Cerebral Metastases using a using a Novel T1 Relaxation-Enhanced Steady-State (T1RESS) MRI Technique$394,207
R01 · FY2025 · CA · contact PI
Improved Detection of Cerebral Metastases using a using a Novel T1 Relaxation-Enhanced Steady-State (T1RESS) MRI Technique$421,040
R01 · FY2024 · CA · contact PI
Improved Detection of Cerebral Metastases using a using a Novel T1 Relaxation-Enhanced Steady-State (T1RESS) MRI Technique$497,643
R01 · FY2023 · CA · contact PI
Twofold Reduction in Gadolinium Dose for Brain MRI Exams using a Novel Unbalanced T1 Relaxation-Enhanced Steady-State (uT1RESS) Technique$184,406
R21 · FY2023 · CA · contact PI
Improved Detection of Cerebral Metastases using a using a Novel T1 Relaxation-Enhanced Steady-State (T1RESS) MRI Technique$531,056
R01 · FY2022 · CA · contact PI
Twofold Reduction in Gadolinium Dose for Brain MRI Exams using a Novel Unbalanced T1 Relaxation-Enhanced Steady-State (uT1RESS) Technique$225,803
R21 · FY2022 · CA · contact PI
Pre-Procedural Evaluation of High-Risk Patients using Next-Generation Radial QISS$355,500
R01 · FY2021 · HL · contact PI
Pre-Procedural Evaluation of High-Risk Patients using Next-Generation Radial QISS$355,500
R01 · FY2020 · HL · contact PI
Pre-Procedural Evaluation of High-Risk Patients using Next-Generation Radial QISS$405,546
R01 · FY2019 · HL · contact PI
Nonenhanced 3T QISS MR Angiography of the Peripheral Arteries$389,136
R01 · FY2019 · HL · contact PI
Pre-Procedural Evaluation of High-Risk Patients using Next-Generation Radial QISS$405,771
R01 · FY2018 · HL · contact PI
Nonenhanced 3T QISS MR Angiography of the Peripheral Arteries$389,107
R01 · FY2018 · HL · contact PI
Nonenhanced 3T QISS MR Angiography of the Peripheral Arteries$389,108
R01 · FY2017 · HL · contact PI
Nonenhanced 3T QISS MR Angiography of the Peripheral Arteries$403,316
R01 · FY2016 · HL · contact PI
Nonenhanced 3T QISS MR Angiography of the Peripheral Arteries$379,388
R01 · FY2016 · HL · contact PI
Projection Imaging of Peripheral Vascular Calcifications$233,512
R21 · FY2016 · HL · contact PI
Projection Imaging of Peripheral Vascular Calcifications$208,745
R21 · FY2015 · HL · contact PI
Non-Contrast Magnetic Resonance Angiography of Peripheral Vascular Disease$446,075
R01 · FY2013 · HL · contact PI
Non-Contrast Magnetic Resonance Angiography of Peripheral Vascular Disease$483,586
R01 · FY2012 · HL · contact PI
Non-Contrast Magnetic Resonance Angiography of Peripheral Vascular Disease$429,730
R01 · FY2011 · HL · contact PI
Non-Contrast Magnetic Resonance Angiography of Peripheral Vascular Disease$432,237
R01 · FY2010 · HL · contact PI
MR-Guided Endovascular Intervention Using Off-Resonance Contrast Angiography$190,625
R21 · FY2010 · HL · contact PI
MR-Guided Endovascular Intervention Using Off-Resonance Contrast Angiography$228,750
R21 · FY2009 · HL · contact PI
CLINICAL TRIAL: PHASE I TRIAL OF INACTIVATED, VERO CELL-CULTURE DERIVED FLU A/H$44,814
M01 · FY2008 · RR · contact PI
INFLUENZA CVD 18000$160,624
M01 · FY2007 · RR · contact PI
INFLUENZA CVD 9000$6,932
M01 · FY2006 · RR · contact PI
MALARIA CVD 16000$3,962
M01 · FY2006 · RR · contact PI
MALARIAVAX, ICC-1132 PHASE I$337,745
M01 · FY2005 · RR
CVD 16000 Malariavax$17,395
M01 · FY2004 · RR
Smash Contrast-Enhanced 3D MR Angiography$252,729
R01 · FY2003 · EB
Smash Contrast-Enhanced 3D MR Angiography$294,020
R01 · FY2002 · HL
BREATH HOLD 3D MRA OF THE CORONARY ARTERIES$248,198
R01 · FY2002 · HL
EVALUATION OF RENAL OXYGENATION STATUS USING MAGNETIC RESONANCE IMAGING$0
M01 · FY2002 · RR
Smash Contrast-Enhanced 3D MR Angiography$320,501
R01 · FY2001 · HL
BREATH HOLD 3D MRA OF THE CORONARY ARTERIES$243,426
R01 · FY2001 · HL
EVALUATION OF RENAL OXYGENATION STATUS USING MAGNETIC RESONANCE IMAGING$0
M01 · FY2001 · RR
Smash Contrast-Enhanced 3D MR Angiography$280,986
R01 · FY2000 · HL
BREATH HOLD 3D MRA OF THE CORONARY ARTERIES$238,799
R01 · FY2000 · HL
EVALUATION OF RENAL OXYGENATION STATUS USING MAGNETIC RESONANCE IMAGING$0
M01 · FY2000 · RR
EVALUATION OF RENAL OXYGENATION STATUS USING MAGNETIC RESONANCE IMAGING$0
M01 · FY2000 · RR
EVALUATION OF RENAL OXYGENATION STATUS USING MAGNETIC RESONANCE IMAGING$0
M01 · FY2000 · RR